Also Read: DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions In October, the FDA issued the ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines, ac ...

Results from a randomized control trial published Nov. 6 in JAMA Network Open show that participants who received mRNA ...

Virologist Beata Halassy says self-treatment worked and was a positive experience — but researchers warn that it is not ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

B-1 immune cells can recognize all sorts of viruses, Yale researchers find. Mimicking them may enable a pan-virus treatment that can address many virus types.

They found that mRNA vaccines that target C. diff cells and the toxins they produce generated a lasting immune response in ...